Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
2.3. BDP1 overall and progression‐free survival curves in ovarian cancer using Kaplan–Meier Plotter
Ask a
question
Favorite
We analyzed overall and progression‐free survival for high and low BDP1 (probe 226290_at) mRNA expression by stage and TP53 mutation status using the Kaplan–Meier Plotter (http://kmplot.com/analysis/) for ovarian cancer 48 ; accessed June 2021 – April 2022. Parameters used in analyses included best cutoff, hazard ratio (HR) with 95% confidence intervals (CIs), log‐rank p‐value, biased arrays were excluded, and JetSet best probe was selected. 48 GSE26193 and GSE63885, Table 1, were the datasets screened using Kaplan–Meier Plotter.
Copyright and License information: ©2022 The Authors. published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
